Thu.Jun 12, 2025

article thumbnail

New Antibody Shot, Enflonsia, Could Help Protect Babies From RSV

Drugs.com

THURSDAY, June 12, 2025 — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug Administration (FDA) has approved a monoclonal.

Virus 289
article thumbnail

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal

BioPharma Drive: Drug Pricing

Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed CureVac in ongoing patent litigation.

Drugs 216
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

June Q2 2025 - Product Update Webinar: AI+ and Curves

Collaborative Drug

Explore new AI+ and curve fitting tools in CDD Vault for structure prediction, docking, and assay analysis. Now available with no setup required.

article thumbnail

Allosteric Covalent Inhibitors of the STAT3 Transcription Factor from Virtual Screening

Covalent Modifiers

Tibor Viktor Szalai, Vincenzo di Lorenzo, Nikolett Péczka, Levente M. Mihalovits, László Petri, Qirat F. Ashraf, Elvin D. de Araujo, Viktor Honti, Dávid Bajusz, and György M. Keserű ACS Medicinal Chemistry Letters 2025 16 (6), 991-997 DOI: 10.1021/acsmedchemlett.4c00622 The STAT family of transcription factors are important signaling hubs, with several of them, particularly STAT3, being emerging oncotargets already investigated in clinical trials.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

The hunger switch in your nose: How smells tell your brain to stop eating

Science Daily: Pharmacology News

A team of scientists has discovered a direct link between the smell of food and feelings of fullness at least in lean mice. This brain circuit, located in the medial septum and triggered by food odors, helps animals eat less by making them feel satiated even before taking a bite. But intriguingly, obese mice lacked this response, highlighting how excess weight may interfere with this satiety mechanism.

237
237
article thumbnail

Zicam and Orajel Swabs Recalled for Possible Fungal Contamination

Drugs.com

THURSDAY, June 12, 2025 — Some nasal and baby teething swabs from Zicam and Orajel are being recalled across the country because they may be contaminated with fungus, U.S. health officials said.The recall was announced by the U.S. Food and Drug A.

Drugs 263

More Trending

article thumbnail

RFK Jr. Installs Critics on Vaccine Recommendation Panel

Drugs.com

THURSDAY, June 12, 2025 — Days after ousting all 17 members of the panel that makes U.S. vaccine recommendations, Health Secretary Robert F. Kennedy Jr. has begun remaking it. On Wednesday, he named eight appointees, three of whom are critics.

Vaccine 256
article thumbnail

Cleaner fish: Tiny healers or hidden spreaders in coral reef ecosystems?

Science Daily: Pharmacology News

Reef "beauty salons" staffed by tiny cleaner fish aren t just for parasite removal they may also shape the microbial life of the entire ecosystem. A fascinating new study shows these bustling fish stations influence which microbes move around the reef, possibly helping or harming coral health. Cleaner gobies, it turns out, don t just offer spa treatments to their fish clients they may also serve as tiny microbiome engineers of the sea.

article thumbnail

Accelerated Biological Aging Tied To Dementia, Stroke Risk

Drugs.com

THURSDAY, June 12, 2025 — A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says.Shorter telomere length in a person’s white blood cells is associated with the two brain diseases, res.

Disease 162
article thumbnail

The 10,000-mile march through fire that made dinosaurs possible

Science Daily: Pharmacology News

Despite Earth's most devastating mass extinction wiping out over 80% of marine life and half of land species, a group of early reptiles called archosauromorphs not only survived but thrived, venturing across the supposedly lifeless tropics to eventually evolve into the dinosaurs and crocodiles we know today. Armed with a groundbreaking model dubbed TARDIS, researchers have reconstructed their ancient dispersal routes, revealing how these resilient reptiles conquered a hostile, post-apocalyptic E

Research 176
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Smartphone App Can Track Huntington's Disease Symptoms

Drugs.com

THURSDAY, June 12, 2025 — Most folks tap away at their smartphone for fun, communication or information.But such tapping may also help them track the progress of a rare degenerative brain disease, researchers say.Five simple smartphone-measured t.

Disease 162
article thumbnail

Accelerated Sequence Alignment for Protein Science with MMseqs2-GPU and NVIDIA NIM

Nvidia Developer: Drug Discovery

Protein sequence alignment—comparing protein sequences for similarities—is fundamental to modern biology and medicine. It illuminates gene functions by. Protein sequence alignment—comparing protein sequences for similarities—is fundamental to modern biology and medicine. It illuminates gene functions by reconstructing evolutionary relationships, technically called homology inference, that can inform drug development.

Science 83
article thumbnail

Most People Open To Sharing Smartwatch Health Data With Doctors

Drugs.com

THURSDAY, June 12, 2025 — A person’s smartwatch can capture a lot of data about their health – and a new study says most folks are willing to share it with doctors.About 94% of people who wear smartwatches or activity trackers are open to sharing da.

Doctors 162
article thumbnail

Webb space telescope reveals starburst galaxies that lit up the early universe

Science Daily: Pharmacology News

Data from NASA's James Webb Space Telescope has revealed dozens of small galaxies that played a starring role in a cosmic makeover that transformed the early universe into the one we know today.

139
139
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

RFK Jr. reveals picks for influential vaccine panel

BioPharma Drive: Drug Pricing

Days after firing all 17 members of the CDC's Advisory Committee for Immunization Practices, the HHS Secretary named a small new committee that includes multiple vaccine critics.

Vaccine 178
article thumbnail

Anti‐Osteoporosis Activity of Lycopene Through ESR1: Network Pharmacology, Molecular Docking, Imaging Technology, and Experimental Validation

Chemical Biology and Drug Design

Schematic of the mechanism of LYC in treating osteoporosis through the ESR1/PI3K/AKT pathway. LYC upregulates ESR1 expression and thus leads to the activation of the PI3K/AKT pathway, thereby inducing hBMSC osteogenic differentiation and attenuating osteoporosis development. ABSTRACT Osteoporosis is a widespread metabolic bone disorder. Lycopene (LYC), a potent antioxidant in tomatoes, has been shown to exhibit anti-osteoporosis effects.

article thumbnail

Screen Time And Troubled Kids: Is There A Vicious Circle?

Drugs.com

THURSDAY, June 12, 2025 — A “vicious circle” might exist between screen time and troubled children, a new evidence review says.Screen time — particularly on video games — appears to contribute to emotional turmoil among children, researchers say.Tho.

Research 147
article thumbnail

Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management

LifeSciVC

By Ram Aiyar, CEO of Korro Bio, as part of the From The Trenches feature of LifeSciVC It has been an extraordinary journey so far and one that continues to humble, inspire and motivate me every day. I’ve had the honor and responsibility of building a visi on that is ambitious while being grounded in scientific rigor. Over the last 4.5 years, Korro has been built by mitigating one layer of risk at a time.

RNA 68
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Inside ARIA, the UK's Bet to Build Scientific Revolutions

Codon

The UK’s Advanced Research and Invention Agency (ARIA) is often referred to as a “UK DARPA” While ARIA is no DARPA clone, many features of the agency are admittedly DARPA-inspired, such as the use of term-limited program managers, which ARIA calls program directors. These program directors serve as chief visionaries for their programs as well as fund and actively manage teams of coordinated external researchers towards a program's well-defined goal.

article thumbnail

Drug Discovery 101 – Webinar Recording

Elrig

Drug Discovery 101 – Webinar Recording Starting a career in drug discovery can feel overwhelming, but breaking down the process makes it more approachable. Our Drug Discovery 101 webinar outlines the entire process from start to finish. Here’s what you need to know to begin your journey in the field. The Basics of Drug Discovery Finding the Right Target The first step in drug discovery is all about identifying and confirming a target—something in the body that a drug can influence to impro

Drugs 52
article thumbnail

Bisexual, Gay and Lesbian Medical Students Less Likely To Finish School

Drugs.com

THURSDAY, June 12, 2025 — Bisexual, gay and lesbian medical students are more likely to leave school before graduation, a new study says.Bisexual medical students were twice as likely to drop out or be dismissed from medical school, and gay and l.

article thumbnail

Driving Toward Billion-Cell Analysis and Biological Breakthroughs with RAPIDS-singlecell

Nvidia Developer: Drug Discovery

The future of cell biology and virtual cell models is dependent on measuring and analyzing data at scale. Single-cell experiments have been growing at an. The future of cell biology and virtual cell models is dependent on measuring and analyzing data at scale. Single-cell experiments have been growing at an incredible rate over the last 10 years, beginning with hundreds of cells and now moving towards new data generation efforts with billions of cells.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

The Importance of Proper CDMO Selection for Rare Disease Drug Programs

Fierce BioTech

The Importance of Proper CDMO Selection for Rare Disease Drug Programs swheeler Thu, 06/12/2025 - 15:18 Thu, 07/17/2025 - 13:00 Resource Type Webinar Chris Olson Promotion Start Wed, 06/18/2025 - 09:00 Promotion End Thu, 12/18/2025 - 09:00 Factors to consider when selecting a CDMO for a rare disease drug: Available capacity and flexibility Financial stability Expertise in formulation development Strong technical experience with difficult to manufacture products Expertise in global regulatory com

Disease 52
article thumbnail

Tal Shnitzer

Broad Institute

Tal Shnitzer By Rose Circeo June 12, 2025 Tal Shnitzer, Ph.D. Senior Machine Learning Scientist Tal Shnitzer is a senior machine learning scientist in the ML4H team at the Broad Institute. She develops machine learning algorithms for disease risk prediction and classification using various biomedical modalities, ranging from clinical measurements such as echocardiograms to wearable sensor data such as Fitbit recordings.

article thumbnail

Bleximenib Shows Promise with Venetoclax and Azacitidine in AML

The Pharma Data

Bleximenib Shows Promise in AML When Combined with Venetoclax and Azacitidine, According to Johnson & Johnson’s Phase 1b Data Presented at EHA 2025 Johnson & Johnson today presented new and promising Phase 1b data demonstrating strong antileukemic activity and a favorable safety profile for bleximenib (JNJ-75276617) in combination with venetoclax (VEN) and azacitidine (AZA) in patients with acute myeloid leukemia (AML) who harbor KMT2A gene rearrangements (KMT2Ar) or NPM1 mutations (NPM1

article thumbnail

Danielle Pace

Broad Institute

Danielle Pace By Rose Circeo June 12, 2025 Danielle Pace Senior Machine Learning Scientist Danielle Pace is a senior machine learning scientist in the Machine Learning for Health team at the Broad Institute of MIT and Harvard. She develops machine learning models that use large clinical datasets, including medical images, electronic health records, ECGs, and genetics, to better understand disease, learn useful data representations, and predict disease risk.

Doctors 52
article thumbnail

Rilzabrutinib Cuts Flares in IgG4-Related Disease; Fast Track Granted in US

The Pharma Data

EULAR 2025: Rilzabrutinib Shows Promise in IgG4-Related Disease — Reduction in Flares and Disease Activity Rilzabrutinib , a Bruton’s tyrosine kinase (BTK) inhibitor currently in clinical development, demonstrated a significant and sustained reduction in disease flares and key disease activity markers in patients with IgG4-related disease (IgG4-RD) , according to new data presented at the European Alliance of Associations for Rheumatology (EULAR) 2025 Congress in Barcelona, Spain (June 11–14).

Disease 40
article thumbnail

Innovations in Generic Drug Manufacturing and Formulation: Transforming Products and Reducing Costs

Drug Patent Watch

"Revolutionizing the Industry: How Innovations in Generic Drug Manufacturing Are Transforming Products and Reducing Costs As the pharmaceutical industry continues to evolve, one thing is clear: the future of generic drugs is not just about cheaper alternatives, but about better, more effective treatments. At the forefront of this revolution are innovations in generic drug manufacturing and formulation, which are transforming products and reducing costs.

article thumbnail

Bristol Myers Squibb Highlights Targeted Protein Degradation Data, Including CELMoD Agents, at EHA 2025

The Pharma Data

Bristol Myers Squibb Highlights Targeted Protein Degradation Advances, Including CELMoD Agents and BCL6 Ligand-Directed Degrader, at EHA 2025 in Milan, Italy Bristol Myers Squibb today revealed new and updated data from its growing portfolio of targeted protein degradation programs during the 2025 European Hematology Association (EHA) Annual Congress, which is currently underway from June 12-15 in Milan, Italy.

article thumbnail

Owning A Dog May Protect Against Eczema

PLOS: DNA Science

About 100 million adults and 100 million children worldwide have the red, flaky, itchy skin of the most common form of eczema, atopic dermatitis, according to the NIH. The condition stems from a misdirected immune response to a substance – an allergen – that does not actually present a threat. Although the exact causes of eczema aren’t well understood, a new study points to an unexpected protective factor: owning a dog.

DNA 63
article thumbnail

Novartis Fabhalta Boosts Hemoglobin in PNH Patients

The Pharma Data

Novartis’ Fabhalta Shows Meaningful Hemoglobin Improvement in PNH Patients, Reinforcing Benefit of Oral Monotherapy Novartis recently announced positive results from its APPULSE-PNH study — a Phase IIIB trial evaluating Fabhalta® (iptacopan) in adult patients with paroxysomal nocturnal hemoglobinuria (PNH) who have a baseline hemoglobin (Hb) level of 10 g/dL or greater and have previously been treated with standard C5 inhibitor therapy (eculizumab or ravulizumab).

article thumbnail

Creating High-Quality Graphics in Clinical SAS: Templates & Best Practices

Quanticate

Utilising the newer SAS graphical procedures such as SGPLOT and SGPANEL rather than the original SAS Graph procedures is becoming more and more popular in statistical programming through their many user friendly utilities, such as overlaying multiple graphics and adding reference lines with ease. However, as with its predecessor, SAS Graph, any requirement for restructure of the graphical elements still proves to be relatively rigid when sticking to these core graphical procedures.

64